REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 486.50
Bid: 484.00
Ask: 486.50
Change: 1.50 (0.31%)
Spread: 2.50 (0.517%)
Open: 480.00
High: 489.50
Low: 480.00
Prev. Close: 485.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Oct 2023 07:00

RNS Number : 4807P
Treatt PLC
10 October 2023

10 October 2023

TREATT PLC

("Treatt" or "the Group")

Trading update for the year ended 30 September 2023

Profit growth returns with resilient revenue performance

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today publishes a trading update for the year ended 30 September 2023 ("FY23").

HIGHLIGHTS:

Resilient revenue growth of 5% (3% in constant currency) at c.拢147m (FY22: 拢140m), despite industry de-stocking headwinds

FY23 profit before tax and exceptional items expected to be in line with Board expectations of c.拢17m, up by c.11% on FY22

Successful pricing actions to recover raw material inflation

China and Coffee growth in line with expectations

Strong cost disciplines and other self-help measures mitigating the impact of customer destocking

Year-end net debt of c.拢10.5m (FY22: 拢22.4m), reflecting record cash generation

UK site transition now complete, providing strong platform for growth

FY23 Performance

Revenue for the year is anticipated to be c.拢147m (FY22: 拢140m), up 5% (3% at constant currency) despite the challenging macro environment and sector destocking, particularly in H2. Sales price increases were successfully implemented to offset raw material price inflation reflecting value-add nature of Treatt's product portfolio.

Core categories, which include Citrus, Synthetic Aromas and Herb Spices & Florals have grown by 1% (revenue: c.拢98m). Premium categories, which include Tea, Health & Wellness, Fruit & Vegetables, are in line with the prior year (revenue: c.拢33m). New markets, which include Coffee, China and Treattzest citrus, have grown by 60% (revenue: c.拢16m).

The Board expects to report profit before tax and exceptional items for FY23 of c.拢17m which is c.11% ahead of prior year (FY22: 拢15.3m), with strong cost discipline and other self-help measures allowing more sales growth to convert to profit.

Operational developments

After substantial investment in our people and production facilities over the last five years, we are well-placed to support the next phase of growth, and do not anticipate any significant increases to the cost base, other than inflation. The group headcount has reduced by 14% since September 2022.

Having implemented a revised currency management strategy, providing increased visibility and controls over our currency exposures, foreign exchange impacts in the year were minimal.

Balance sheet

The Group ended the year with net debt of c.拢10.5m (FY22: 拢22.4m). With the transition to the new site now complete, capital expenditure has returned to normalised levels. The Group completed refinancing of the UK bank facility for 拢25m with HSBC with a minimum term of three years.

Daemmon Reeve, CEO of Treatt, commented:

"We delivered positive growth in sales and profit for the year, reflecting the significant price increase programme and ongoing resilience in our beverage end markets. Revenues in the second half of the year were impacted by certain customers reducing inventories in response to interest rate rises. However, we are seeing some early signs of a reversal of this temporary destocking effect, and have also been able to mitigate the effect of this impact with strong cost discipline and other self- help measures. With our unique value-add products, in conjunction with the new site transition now complete, we are confident in Treatt's long-term prospects."

Treatt's results for the year ended 30 September 2023 are expected to be announced on 28 November 2023.

Enquiries:

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Mike Burke

Financial PR

MHP +44 (0) 20 3128 8789

Tim Rowntree

Eleni Menikou

Catherine Chapman

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

The Group employs approximately 400 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

For further information about the Group, visit www.treatt.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTKKLFBXBLFFBE
Date   Source Headline
11th May 20208:53 amRNSHolding(s) in Company
7th May 20203:48 pmRNSHolding(s) in Company
6th May 20204:23 pmRNSHolding(s) in Company
29th Apr 202012:51 pmRNSDisclosure of rights attached to equity shares
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:03 pmRNSPrice Monitoring Extension
24th Apr 20202:12 pmRNSHolding(s) in Company
23rd Apr 20206:23 pmRNSDirector/PDMR Shareholding
17th Apr 20202:06 pmRNSSID and Board Committee Changes
14th Apr 20204:36 pmRNSHolding(s) in Company
9th Apr 20204:43 pmRNSHolding(s) in Company
9th Apr 20204:19 pmRNSTR:1 notification of major holdings
7th Apr 20207:00 amRNSTrading update
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20205:15 pmRNSDirector/PDMR Shareholding
23rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 202010:38 amRNSHolding(s) in Company
12th Mar 20204:40 pmRNSPrice Monitoring Extension
18th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:29 pmRNSHolding(s) in Company
6th Feb 20209:04 amRNSHolding(s) in Company
5th Feb 20203:53 pmRNSVoting Rights and Capital
31st Jan 20204:54 pmRNSResult of AGM
29th Jan 20205:26 pmRNSDirector/PDMR Shareholding
29th Jan 20205:10 pmRNSHolding(s) in Company
21st Jan 20203:21 pmRNSHolding(s) in Company
21st Jan 20201:26 pmRNSHolding(s) in Company
17th Jan 20203:28 pmRNSDirector/PDMR Shareholding
16th Jan 20205:07 pmRNSHolding(s) in Company
9th Jan 20202:28 pmRNSDirector/PDMR Shareholding - Replacement
8th Jan 20205:04 pmRNSDirector/PDMR Shareholding
7th Jan 20205:16 pmRNSHolding(s) in Company
6th Jan 202011:18 amRNSDirector/PDMR Shareholding
24th Dec 201910:54 amRNSVoting Rights and Capital
18th Dec 20194:03 pmRNSNotification of Transactions of Directors
17th Dec 20194:04 pmRNSDirector/PDMR Shareholding
10th Dec 201912:15 pmRNSAnnual Report
6th Dec 20194:12 pmRNSHolding(s) in Company
2nd Dec 20194:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Dec 20194:43 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Nov 20197:00 amRNSFinal Results
25th Nov 201912:07 pmRNSSecond Price Monitoring Extn
25th Nov 201912:02 pmRNSPrice Monitoring Extension
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
21st Nov 20193:11 pmRNSBoard Committee Change
6th Nov 20199:44 amRNSHolding(s) in Company
25th Oct 20194:40 pmRNSSecond Price Monitoring Extn
25th Oct 20194:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.